Abstract
In recent clinical practice, patients presenting with chief complaint of cervical lymphadenopathy[1] has been progressively increasing year after year and as a result, the main causes have been becoming more complicated...
Highlights
In recent clinical practice, patients presenting with chief complaint of cervical lymphadenopathy[1] has been progressively increasing year after year and as a result, the main causes have been becoming more complicated
For cervical lymph node lesions, Ultrasound-guided 16G needle biopsy achieved 100% sensitivity, 96% specificity, and 98% accuracy, whereas Ultrasound-guided 18G needle biopsy achieved 100% sensitivity, 94% specificity, and 97% accuracy respectively
Ultrasound-guided percutaneous biopsy is able to ensure a high accuracy of diagnosis and thereby reduce the occurrence of complications in patients with cervical lymph node lesions
Summary
Patients presenting with chief complaint of cervical lymphadenopathy[1] has been progressively increasing year after year and as a result, the main causes have been becoming more complicated. Clinically diagnosed cervical lymph node lesions, based on pathological diagnosis of excision biopsy, can achieve high diagnostic accuracy, yet traumatic, sampling difficulties and other issues are encountered. This article explores the diagnostic value of clinical ultrasound guided percutaneous biopsy for cervical lymph node lesions [3].Cervical lymphadenopathy refers to the disease or enlargement of the lymph nodes of the neck, and it’s considered more of a physical sign or symptom rather than a diagnosis. Numerous Infectious causes of cervical lymphadenopathy including most importantly HIV, Tuberculosis and Chicken pox exist. For malignant diseases, this lymphadenopathy can be either reactive or metastatic[4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have